CLDN5 and cancer: According to the findings of the Kaplan-Meier analysis, increased CLDN5 expression was associated with a poor prognosis in four types of cancers, namely, COAD, GBM, KIRP, STAD, LUSC, and UVM (Supplementary Figure 2B).